Squarepoint’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-193,565
| Closed | -$7.61M | – | 4400 |
|
|
2023
Q2 | $7.61M | Buy |
+193,565
| New | +$6.83M | 0.02% | 820 |
|
|
2023
Q1 | – | Sell |
-11,824
| Closed | -$253K | – | 3978 |
|
|
2022
Q4 | $253K | Sell |
11,824
-45,839
| -79% | -$978K | ﹤0.01% | 2667 |
|
|
2022
Q3 | $1.03M | Buy |
57,663
+12,462
| +28% | +$164K | 0.01% | 1751 |
|
|
2022
Q2 | $435K | Buy |
+45,201
| New | +$567K | ﹤0.01% | 2087 |
|
|
2022
Q1 | – | Sell |
-45,155
| Closed | -$755K | – | 3749 |
|
|
2021
Q4 | $755K | Sell |
45,155
-40,529
| -47% | -$664K | ﹤0.01% | 1876 |
|
|
2021
Q3 | $1.39M | Sell |
85,684
-4,323
| -5% | -$47K | ﹤0.01% | 1380 |
|
|
2021
Q2 | $568K | Sell |
90,007
-5,230
| -5% | -$33.7K | ﹤0.01% | 2037 |
|
|
2021
Q1 | $589K | Buy |
95,237
+37,481
| +65% | +$228K | ﹤0.01% | 1898 |
|
|
2020
Q4 | $399K | Buy |
+57,756
| New | +$370K | ﹤0.01% | 1985 |
|
|
2020
Q3 | – | Sell |
-35,892
| Closed | -$183K | – | 2947 |
|
|
2020
Q2 | $183K | Sell |
35,892
-48,963
| -58% | -$204K | ﹤0.01% | 1845 |
|
|
2020
Q1 | $292K | Buy |
84,855
+51,310
| +153% | +$300K | 0.01% | 1316 |
|
|
2019
Q4 | $288K | Buy |
+33,545
| New | +$120K | ﹤0.01% | 2060 |
|
|
2019
Q3 | – | Sell |
-12,557
| Closed | -$16K | – | 2766 |
|
|
2019
Q2 | $16K | Buy |
+12,557
| New | +$17.2K | ﹤0.01% | 2315 |
|
|
2019
Q1 | – | Sell |
-14,888
| Closed | -$18K | – | 2523 |
|
|
2018
Q4 | $18K | Sell |
14,888
-6,412
| -30% | -$12.4K | ﹤0.01% | 1874 |
|
|
2018
Q3 | $50K | Buy |
+21,300
| New | +$53.1K | ﹤0.01% | 1920 |
|
|
2018
Q1 | – | Sell |
-10,014
| Closed | -$31K | – | 2277 |
|
|
2017
Q4 | $31K | Sell |
10,014
-53,800
| -84% | -$151K | ﹤0.01% | 2036 |
|
|
2017
Q3 | $180K | Sell |
63,814
-294
| -0.5% | -$794 | ﹤0.01% | 1415 |
|
|
2017
Q2 | $164K | Sell |
64,108
-9,760
| -13% | -$26.6K | ﹤0.01% | 1347 |
|
|
2017
Q1 | $270K | Sell |
73,868
-201,201
| -73% | -$850K | 0.01% | 1139 |
|
|
2016
Q4 | $1.33M | Buy |
+275,069
| New | +$8.17M | 0.05% | 407 |
|
|
2016
Q3 | – | Sell |
-4,200
| Closed | -$214K | – | 1328 |
|
|
2016
Q2 | $214K | Buy |
+4,200
| New | +$209K | 0.01% | 867 |
|
|
2016
Q1 | – | Sell |
-5,100
| Closed | -$401K | – | 1515 |
|
|
2015
Q4 | $401K | Buy |
+5,100
| New | +$295K | 0.04% | 654 |
|
|
2015
Q2 | – | Sell |
-5,800
| Closed | -$270K | – | 642 |
|
|
2015
Q1 | $270K | Buy |
+5,800
| New | +$301K | 0.09% | 311 |
|
Squarepoint's ISEE Position: Q3 2023 in Review
Squarepoint sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 193,565 shares — an estimated $7.61M sold.
Squarepoint first reported a position in ISEE in Q1 2015 and held it in 23 quarters. The position peaked at $7.61M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Squarepoint reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Squarepoint sold 193,565 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $7.61M.
- Squarepoint first reported a position in IVERIC bio, Inc. Common Stock in Q1 2015 and held it in 23 quarters.
- Squarepoint's IVERIC bio, Inc. Common Stock position peaked at $7.61M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.